Sodium valproate (VPA) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-Sodium valproate (VPA) antibodies (anti-Sodium valproate, anti-VPA) and diagnostic hapten-carrier conjugates BSA-Sodium valproate (VPA), OVA-Sodium valproate (VPA), KLH-Sodium valproate (VPA) antigens for Epilepsy VPA detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Epilepsy diagnostics products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-VPA-Ag01	BSA-Sodium valproate (VPA)	$756.00
GMP-SMT-VPA-Ag02	OVA-Sodium valproate (VPA)	$756.00
GMP-SMT-VPA-Ab01	Anti-human Sodium valproate (VPA) mouse monoclonal antibody (mAb)	$1953.00
GMP-SMT-VPA-Ab02	Anti-human Sodium valproate (VPA) human monoclonal antibody (mAb)	$1953.00

Size： 1mg | 10mg | 100mg

Product Description

BSA-Sodium valproate (VPA)

Cat No.	GMP-SMT-VPA-Ag01
Product Name	BSA-Sodium valproate (VPA)
Target	Sodium valproate (VPA)
Expression platform	Synthetic
Bioactivity validation	Sodium valproate (VPA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VPA level test of Epilepsy (toxicity) and related syndrome evaluation
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Sodium valproate (VPA) / OVA-Sodium valproate (VPA) is Synthetic.
Purity	High (TBD)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Sodium valproate (VPA)

Cat No.	GMP-SMT-VPA-Ag02
Product Name	OVA-Sodium valproate (VPA)
Target	Sodium valproate (VPA)
Expression platform	Synthetic
Bioactivity validation	Sodium valproate (VPA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VPA level test of Epilepsy (toxicity) and related syndrome evaluation/td>
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Sodium valproate (VPA) / OVA-Sodium valproate (VPA) is Synthetic.
Purity	High (TBD)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Sodium valproate (VPA) mouse monoclonal antibody (mAb)

Cat No.	GMP-SMT-VPA-Ab01
Product Name	Anti-human Sodium valproate (VPA) mouse monoclonal antibody (mAb)
Target	Sodium valproate (VPA)
Expression platform	hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Sodium valproate (VPA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Sodium valproate (VPA) antibodies in VPA level test of Epilepsy (toxicity) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human Sodium valproate (VPA) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
Purity	High (TBD)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Sodium valproate (VPA) human monoclonal antibody (mAb)

Cat No.	GMP-SMT-VPA-Ab02
Product Name	Anti-human Sodium valproate (VPA) human monoclonal antibody (mAb)
Target	Sodium valproate (VPA)
Expression platform	hybridoma
Isotypes	Human IgG1
Bioactivity validation	Sodium valproate (VPA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Sodium valproate (VPA) antibodies in VPA level test of Epilepsy (toxicity) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human Sodium valproate (VPA) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO.
Purity	Purity: ≥95% （SDS-PAGE）
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Supplied as a 0.2 μM filtered solution of PBS, PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Valproate (VPA) and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy and bipolar disorder and prevent migraine headaches. They are useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures. They can be given intravenously or by mouth, and the tablet forms exist in both long- and short-acting formulations.

About GDU